Journal Article

Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience

Bagot, Martine, Hodak, Emmilia, Kim, Ellen J., Geskin, Larisa J.

2021

Overview

Mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma, is a disease typically with an indolent course that is initially characterized by localized patches and plaques. In the early stages of the disease, treatment involves skin-directed therapies (SDTs) such as topical corticosteroids and retinoids. Chlormethine gel (also known as mechlorethamine) was the first SDT purposely developed to treat MF and is currently endorsed by international guidelines for the treatment of adult patients with MF as a first-line therapy. While chlormethine is an efficacious therapy, its usage may be complicated by the development of cutaneous reactions at the sites of application. Herein, we discuss the supportive guidelines for MF and the suitability of chlormethine as a therapeutic option in patients with MF. In addition, we present real-world experience on the use of chlormethine gel from clinics in the USA, Israel, and France with the aim of demonstrating the efficacy of chlormethine gel in routine clinical practice and outlining strategies that are being used to manage emergent cutaneous reactions. Infographic

• Publisher: Springer Healthcare,Springer,Springer Nature B.V
• Subject: Aqueous solutions / Chemotherapy / Cutaneous T cell lymphoma / Dermatitis / Dermatology / Disease / Drug therapy / FDA approval / Fungal infections / Gels (Pharmacy) / Internal Medicine / Lesions / Lymphoma / Medical prognosis / Medicine / Medicine & Public Health / Mycosis fungoides / Nitrogen mustards / Oral and Maxillofacial Surgery / Patients / Plastic Surgery / Quality of life / Quality of Life Research / Review / Skin / Skin lesions